Literature DB >> 8974844

An in vivo model of chronic optic nerve ischemia: the dose-dependent effects of endothelin-1 on the optic nerve microvasculature.

G A Cioffi1, S Orgül, E Onda, D R Bacon, E M Van Buskirk.   

Abstract

The purpose of this study was to evaluate the effects induced by chronic microapplication of endothelin-1 on the anterior optic nerve microvasculature and to determine the dose-response characteristics of endothelin-1 on this vascular bed. Daily dosages between 4.69 x 10(-4) and 9.0 x 10(-1) micrograms/day of endothelin-1 were delivered continually over 3 days, and at a constant flow rate, to the perineural region of the anterior optic nerve of 15 albino rabbits via osmotically-driven minipumps. The vasomotor effect of local endothelin-1 on the microvasculature of the optic nerve was examined using intraluminal microvascular corrosion casting technique. The vasomotor effects were quantified by measuring the relative amount of vasoconstriction of the arterioles supplying the anterior optic nerve (primary and secondary branches of the short posterior ciliary arteries). The average constriction was calculated for the endothelin-treated eyes and the untreated, contralateral eyes. The mean vasoconstriction in the endothelin treated eyes ranged from 14.7% to 30.0% and was highly correlated with the logarithmic value of the daily dose of endothelin-1 (R2 = 0.59, p = 0.00083). The interocular difference (between treated and untreated eyes) of the optic nerve vasoconstriction ranged from 0-19% (mean +/- SD: 7.23 +/- 5.7%). This interocular difference also correlated highly with the log of the daily endothelin-1 dosage (R2 = 0.80; p < 0.0001). By additionally accounting for the weight and sex in a multiple linear regression function, the correlation was markedly improved (R2 = 0.92; p < 0.0001). In conclusion, the microvasculature supplying the anterior optic nerve of the rabbit demonstrates a dose-dependent vasoconstriction with chronic local application of endothelin-1. This in vivo, experimental model offers a titratable method with which the effects of chronic vasoconstriction and vascular insufficiency on the optic nerve can be examined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8974844     DOI: 10.3109/02713689508995821

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  19 in total

1.  Factors affecting the use of multifocal electroretinography to monitor function in a primate model of glaucoma.

Authors:  Brad Fortune; Grant Cull; Lin Wang; E Michael Van Buskirk; George A Cioffi
Journal:  Doc Ophthalmol       Date:  2002-09       Impact factor: 2.379

Review 2.  A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

Review 3.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

4.  The non-human primate experimental glaucoma model.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2015-06-09       Impact factor: 3.467

Review 5.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

6.  Endothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion Cells.

Authors:  Shaoqing He; Yong H Park; Thomas Yorio; Raghu R Krishnamoorthy
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09-01       Impact factor: 4.799

7.  Ischemic model of optic nerve injury.

Authors:  George A Cioffi
Journal:  Trans Am Ophthalmol Soc       Date:  2005

8.  Relationship Between Juxtapapillary Choroidal Volume and Beta-Zone Parapapillary Atrophy in Eyes With and Without Primary Open-Angle Glaucoma.

Authors:  Michael Sullivan-Mee; Nimesh B Patel; Denise Pensyl; Clifford Qualls
Journal:  Am J Ophthalmol       Date:  2015-07-02       Impact factor: 5.258

9.  Experimental models for analysis of oligodendrocyte pathophysiology in stroke.

Authors:  Ken Arai; Eng H Lo
Journal:  Exp Transl Stroke Med       Date:  2009-10-24

10.  Matrix metalloproteinase-9 expression in retinal ganglion cell layer and effect of topically applied brimonidine tartrate 0.2% therapy on this expression in an endothelin-1-induced optic nerve ischemia model.

Authors:  Zeynep Aktas; Gokhan Gurelik; Pinar Uyar Göçün; Nalan Akyürek; Merih Onol; Berati Hasanreisoğlu
Journal:  Int Ophthalmol       Date:  2009-07-21       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.